Doxepin: Revision history

22 September 2019

• curprev 18:1818:18, 22 September 2019‎ ClaireLewis talk contribs‎ 3,123 bytes +27‎ No edit summary

20 April 2018

• curprev 22:3322:33, 20 April 2018‎ Dteoli talk contribs‎ 3,096 bytes −15‎ →‎Depression and/or anxiety
• curprev 22:3222:32, 20 April 2018‎ Dteoli talk contribs‎ 3,111 bytes +9‎ →‎Pediatric Dosing
• curprev 22:3122:31, 20 April 2018‎ Dteoli talk contribs‎ 3,102 bytes +39‎ →‎Pediatric Dosing
• curprev 22:3022:30, 20 April 2018‎ Dteoli talk contribs‎ 3,063 bytes +659‎ →‎Pediatric Dosing

27 October 2016

• curprev 15:3915:39, 27 October 2016‎ Neil.m.young talk contribs‎ 2,404 bytes −1‎ Text replacement - "* " to "*"

29 September 2016

• curprev 02:5802:58, 29 September 2016‎ ClaireLewis talk contribs‎ 2,405 bytes −46‎ →‎Adverse Reactions
• curprev 02:5202:52, 29 September 2016‎ ClaireLewis talk contribs‎ 2,451 bytes −140‎ →‎Contraindications

24 September 2016

• curprev 05:2205:22, 24 September 2016‎ Rossdonaldson1 talk contribs‎ 2,591 bytes +48‎ →‎Adult Dosing

23 September 2016

• curprev 21:4021:40, 23 September 2016‎ Kaoru talk contribs‎ 2,543 bytes +2,543‎ Created page with "==Administration== *Type: Insomnia; Tricyclic Antidepressants (TCAs) *Dosage Forms: 10, 25, 50, 75, 100, 150; 10/mL *Routes of Administration: PO *Common Trade Names: Silenor,..."